The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.
London's FTSE 100 surged to record highs while the Bank of England kept interest rates steady. AstraZeneca and Sainsbury's impressed with robust earnings in a dramatic trading session.
In a dramatic policy shift, Chancellor Rachel Reeves abolishes stamp duty on share trading to boost UK investment competitiveness, following AstraZeneca's stark warning about London's declining appeal.